Sökning: onr:"swepub:oai:gup.ub.gu.se/238282" > Anti-infective effi...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05599naa a2200709 4500 | |
001 | oai:gup.ub.gu.se/238282 | |
003 | SwePub | |
008 | 240910s2016 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:133683795 | |
009 | oai:DiVA.org:ri-124 | |
024 | 7 | a https://gup.ub.gu.se/publication/2382822 URI |
024 | 7 | a https://doi.org/10.1016/j.peptides.2016.04.0052 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1336837952 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:ri:diva-1242 URI |
040 | a (SwePub)gud (SwePub)kid (SwePub)ri | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Björn, Camillau RISE,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Medicinteknik,Pergamum AB, Sweden; University of Gothenburg, Sweden4 aut0 (Swepub:ri)CamillaBj@ri.se |
245 | 1 0 | a Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r |
264 | 1 | b Elsevier BV,c 2016 |
500 | a SP Chemistry, Materials and Surfaces Publication nr A3668 | |
520 | a Antimicrobial peptides (AMPs) have emerged as a new class of drug candidates for the treatment of infectious diseases. Here we describe a novel AMP, HLR1r, which is structurally derived from the human milk protein lactoferrin and demonstrates a broad spectrum microbicidal action in vitro. The minimum concentration of HLR1r needed for killing >= 99% of microorganisms in vitro, was in the range of 3-50 mu g/ml for common Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and for the yeast Candida albicans, when assessed in diluted brain-heart infusion medium. We found that HLR1r also possesses anti-inflammatory properties as evidenced by inhibition of tumor necrosis factor alpha (TNF-alpha) secretion from human monocyte-derived macrophages and by repression of interleukin-6 (IL-6) and plasminogen activator inhibitor-1 (PAI-1) secretion from human mesothelial cells, without any cytotoxic effect observed at the concentration range tested (up to 400 mu g/ml). HLR1r demonstrated pronounced anti-infectious effect in in vivo experimental models of cutaneous candidiasis in mice and of excision wounds infected with MRSA in rats as well as in an ex vivo model of pig skin infected with S. aureus. In conclusion, HLR1r may constitute a new therapeutic alternative for local treatment of skin infections. (C) 2016 Elsevier Inc. All rights reserved. | |
650 | 7 | a NATURVETENSKAPx Biologix Biokemi och molekylärbiologi0 (SwePub)106022 hsv//swe |
650 | 7 | a NATURAL SCIENCESx Biological Sciencesx Biochemistry and Molecular Biology0 (SwePub)106022 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmakologi och toxikologi0 (SwePub)301022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmacology and Toxicology0 (SwePub)301022 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Mikrobiologi inom det medicinska området0 (SwePub)301092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Microbiology in the medical area0 (SwePub)301092 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmaceutiska vetenskaper0 (SwePub)301012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmaceutical Sciences0 (SwePub)301012 hsv//eng |
653 | a AMP | |
653 | a Wound infection | |
653 | a Antibiotic resistance | |
653 | a Staphylococcus aureus | |
653 | a MRSA | |
653 | a Candida albicans | |
653 | a soft-tissue infections | |
653 | a host-defense peptides | |
653 | a resistant-bacteria | |
653 | a monocytic cells | |
653 | a skin | |
653 | a immune | |
653 | a region | |
653 | a model | |
653 | a mice | |
653 | a susceptibility | |
653 | a Biochemistry & Molecular Biology | |
653 | a Pharmacology & Pharmacy | |
653 | a AMP | |
700 | 1 | a Mahlapuu, Margit,d 1972u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Pergamum AB, Sweden; University of Gothenburg, Sweden4 aut0 (Swepub:gu)xmahma |
700 | 1 | a Mattsby-Baltzer, Inger,d 1949u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,University of Gothenburg, Sweden4 aut0 (Swepub:gu)xmatin |
700 | 1 | a Håkansson, Joakimu RISE,Medicinteknik,Pergamum AB, Sweden4 aut0 (Swepub:ri)JoakimHa@ri.se |
710 | 2 | a Göteborgs universitetb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org |
773 | 0 | t Peptidesd : Elsevier BVg 81, s. 21-28q 81<21-28x 0196-9781x 1873-5169 |
856 | 4 8 | u https://gup.ub.gu.se/publication/238282 |
856 | 4 8 | u https://doi.org/10.1016/j.peptides.2016.04.005 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:133683795 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:ri:diva-124 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy